GLENN CHIANG

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology NEWPORT BEACH, CA NPI 1285697227

General Payments — all program years on this page

$1,385.67

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 54
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $434.28 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $402.0115
Education $32.271

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $337.6718
2019 $388.1315
2020 $52.953
2023 $172.642
2024 $434.2816

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086150707 Bayer Healthcare Pharmaceuticals Inc. $21.42 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086776207 Novartis Pharmaceuticals Corporation $22.87 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093880986 Alexion Pharmaceuticals, Inc. $33.75 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096571192 Novo Nordisk Inc $16.97 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097380223 Novo Nordisk Inc $32.27 10/28/2024 Education Undisputed 01/23/2026 View at CMS
1104315850 AstraZeneca Pharmaceuticals LP $29.20 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105626673 AstraZeneca Pharmaceuticals LP $25.84 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105852428 AstraZeneca Pharmaceuticals LP $30.23 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111548700 Amgen Inc. $34.04 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117949157 Boehringer Ingelheim Pharmaceuticals, Inc. $16.82 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118875062 Otsuka America Pharmaceutical, Inc. $19.93 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124043981 Vifor Pharma, Inc. $26.92 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133421165 Averitas Pharma Inc. $30.00 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141520759 CALLIDITAS THERAPEUTICS US INC. $40.23 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146675262 Ardelyx, Inc. $25.26 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154200028 Fresenius USA Marketing, Inc. $28.53 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.